Hartstein Ilan, Khwarg Steven, Przydryga Johan
La Palma Eye Care Center, La Palma, CA, USA.
Curr Med Res Opin. 2005 Feb;21(2):255-60. doi: 10.1185/030079905x26252.
Evaluate the efficacy of a polymer hydroxypropyl guar (HP-Guar) gellable lubricant eye drop (Systane* Lubricant Eye Drops) in reducing dry eye signs and symptoms among dry eye patients who exhibited at least moderate signs and symptoms.
168 patients with moderate dry eye signs and symptoms were enrolled at 29 sites in this open label study. The mean age of patients was 62 years with a minimum age of 28 years and a maximum of 90 years. One hundred and forty-seven patients completed the study, 111 female and 35 male, excluding 1 subject (gender not captured). In order to be included in the study, subjects were required to have a total corneal staining score > or = 4 (NEI grid) in at least one eye, with a grade > or = 2 in at least one zone of the same eye. Patients also had to indicate that their eyes 'felt dry enough to want to use eye drops' at least 'some of the time' on a standardized frequency scale. Eligible patients were dispensed a run-in drop (Opti-Free Express Rewetting Drops*) to use QID for 7 days, and then examined. Patients continuing to meet the inclusion criteria were dispensed the test drops (HP-Guar gellable lubricant eye drops) to use QID, and re-examined on Day 28. At each visit, corneal and conjunctival staining were measured, and six ocular discomfort symptoms were rated on a standardized 0-4 severity scale. At Days 0 and 28, patients subjectively rated product acceptability using a Likert scale.
No significant changes in corneal or conjunctival staining were observed with the use of the run-in drop. After 28 days of test drop use, there was a statistically significant reduction in corneal staining (p < 0.0001). Ninety-four percent of patients improved from baseline, with mean reduction in total corneal staining of 4.1 units (0-15 total scale) (62%). Conjunctival staining also improved significantly (p < 0.0001) with a mean total reduction of 3.1 (59%). Patients experienced statistically significant symptomatic relief from day 0 to day 28 for all six ocular discomfort severity questions (p < 0.0001).
Lubricating drops effectively relieved signs and symptoms associated with moderate dry eye, with measurable improvements evident in both objective staining and subjective questionnaire measures after 28 days in this study population.
评估一种聚合物羟丙基瓜尔胶(HP - 瓜尔胶)可凝胶化润滑滴眼液(思然*润滑滴眼液)在减轻至少有中度体征和症状的干眼患者干眼体征和症状方面的疗效。
在这项开放标签研究中,29个研究点招募了168例有中度干眼体征和症状的患者。患者的平均年龄为62岁,最小年龄28岁,最大年龄90岁。147例患者完成了研究,其中女性111例,男性35例,排除1例(未记录性别)。为纳入研究,受试者至少一只眼睛的总角膜染色评分≥4(NEI网格),且同一只眼睛至少一个区域的分级≥2。患者还必须在标准化频率量表上表明他们的眼睛至少“有时”“感觉干燥到想用滴眼液”。符合条件的患者被给予一种导入性滴眼液(倍然*润眼液),每天使用4次,共7天,然后进行检查。继续符合纳入标准的患者被给予试验滴眼液(HP - 瓜尔胶可凝胶化润滑滴眼液),每天使用4次,并在第28天再次检查。每次就诊时,测量角膜和结膜染色情况,并使用标准化的0 - 4严重程度量表对六种眼部不适症状进行评分。在第0天和第28天,患者使用李克特量表主观评价产品可接受性。
使用导入性滴眼液后,角膜或结膜染色未观察到显著变化。使用试验滴眼液28天后,角膜染色有统计学显著降低(p < 0.)。94%的患者较基线有所改善,总角膜染色平均降低4.1个单位(总评分0 - 15)(62%)。结膜染色也有显著改善(p < 0.),平均总降低3.1(59%)。在第0天到第28天,对于所有六个眼部不适严重程度问题,患者的症状都有统计学显著缓解(p < 0.)。
在本研究人群中,润滑滴眼液有效缓解了与中度干眼相关的体征和症状,28天后在客观染色和主观问卷测量方面均有明显的可测量改善。